vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and SOLAREDGE TECHNOLOGIES, INC. (SEDG). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $335.4M, roughly 1.5× SOLAREDGE TECHNOLOGIES, INC.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -39.4%, a 46.2% gap on every dollar of revenue. On growth, SOLAREDGE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (70.9% vs -1.7%). Over the past eight quarters, SOLAREDGE TECHNOLOGIES, INC.'s revenue compounded faster (28.1% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
SolarEdge Technologies, Inc. is an Israeli company that developed a DC optimized inverter system.
MD vs SEDG — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $335.4M |
| Net Profit | $33.7M | $-132.1M |
| Gross Margin | — | 22.2% |
| Operating Margin | 9.9% | -14.4% |
| Net Margin | 6.8% | -39.4% |
| Revenue YoY | -1.7% | 70.9% |
| Net Profit YoY | 10.5% | 54.0% |
| EPS (diluted) | $0.40 | $-2.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $335.4M | ||
| Q3 25 | $492.9M | $340.2M | ||
| Q2 25 | $468.8M | $289.4M | ||
| Q1 25 | $458.4M | $219.5M | ||
| Q4 24 | $502.4M | $196.2M | ||
| Q3 24 | $511.2M | $235.4M | ||
| Q2 24 | $504.3M | $265.4M | ||
| Q1 24 | $495.1M | $204.4M |
| Q4 25 | $33.7M | $-132.1M | ||
| Q3 25 | $71.7M | $-50.1M | ||
| Q2 25 | $39.3M | $-124.7M | ||
| Q1 25 | $20.7M | $-98.5M | ||
| Q4 24 | $30.5M | $-287.4M | ||
| Q3 24 | $19.4M | $-1.2B | ||
| Q2 24 | $-153.0M | $-130.8M | ||
| Q1 24 | $4.0M | $-157.3M |
| Q4 25 | — | 22.2% | ||
| Q3 25 | — | 21.2% | ||
| Q2 25 | — | 11.1% | ||
| Q1 25 | — | 8.0% | ||
| Q4 24 | — | -57.2% | ||
| Q3 24 | — | -309.1% | ||
| Q2 24 | — | -4.1% | ||
| Q1 24 | — | -12.8% |
| Q4 25 | 9.9% | -14.4% | ||
| Q3 25 | 13.8% | -10.3% | ||
| Q2 25 | 12.8% | -39.9% | ||
| Q1 25 | 7.0% | -46.8% | ||
| Q4 24 | 7.8% | -134.4% | ||
| Q3 24 | 6.6% | -471.8% | ||
| Q2 24 | -31.3% | -60.4% | ||
| Q1 24 | 3.2% | -85.0% |
| Q4 25 | 6.8% | -39.4% | ||
| Q3 25 | 14.5% | -14.7% | ||
| Q2 25 | 8.4% | -43.1% | ||
| Q1 25 | 4.5% | -44.9% | ||
| Q4 24 | 6.1% | -146.5% | ||
| Q3 24 | 3.8% | -522.8% | ||
| Q2 24 | -30.3% | -49.3% | ||
| Q1 24 | 0.8% | -77.0% |
| Q4 25 | $0.40 | $-2.21 | ||
| Q3 25 | $0.84 | $-0.84 | ||
| Q2 25 | $0.46 | $-2.13 | ||
| Q1 25 | $0.24 | $-1.70 | ||
| Q4 24 | $0.37 | $-5.00 | ||
| Q3 24 | $0.23 | $-21.58 | ||
| Q2 24 | $-1.84 | $-2.31 | ||
| Q1 24 | $0.05 | $-2.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $493.2M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $427.5M |
| Total Assets | $2.2B | $2.2B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $493.2M | ||
| Q3 25 | $340.1M | $498.6M | ||
| Q2 25 | $224.7M | $758.0M | ||
| Q1 25 | $99.0M | $651.6M | ||
| Q4 24 | $229.9M | $585.9M | ||
| Q3 24 | $103.8M | $678.8M | ||
| Q2 24 | $19.4M | $689.8M | ||
| Q1 24 | $8.0M | $680.6M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $427.5M | ||
| Q3 25 | $890.7M | $479.8M | ||
| Q2 25 | $833.8M | $513.2M | ||
| Q1 25 | $789.2M | $594.2M | ||
| Q4 24 | $764.9M | $658.3M | ||
| Q3 24 | $732.5M | $930.9M | ||
| Q2 24 | $706.5M | $2.1B | ||
| Q1 24 | $856.2M | $2.2B |
| Q4 25 | $2.2B | $2.2B | ||
| Q3 25 | $2.2B | $2.2B | ||
| Q2 25 | $2.1B | $2.5B | ||
| Q1 25 | $2.0B | $2.5B | ||
| Q4 24 | $2.2B | $2.6B | ||
| Q3 24 | $2.1B | $2.8B | ||
| Q2 24 | $2.0B | $3.9B | ||
| Q1 24 | $2.2B | $4.2B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $52.6M |
| Free Cash FlowOCF − Capex | — | $43.3M |
| FCF MarginFCF / Revenue | — | 12.9% |
| Capex IntensityCapex / Revenue | — | 2.8% |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $80.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $52.6M | ||
| Q3 25 | $137.3M | $25.6M | ||
| Q2 25 | $137.2M | $-7.8M | ||
| Q1 25 | $-117.5M | $33.8M | ||
| Q4 24 | $133.0M | $37.8M | ||
| Q3 24 | $91.8M | $-89.3M | ||
| Q2 24 | $107.0M | $-44.8M | ||
| Q1 24 | $-125.2M | $-217.0M |
| Q4 25 | — | $43.3M | ||
| Q3 25 | — | $22.8M | ||
| Q2 25 | — | $-9.1M | ||
| Q1 25 | — | $23.7M | ||
| Q4 24 | — | $25.5M | ||
| Q3 24 | — | $-136.7M | ||
| Q2 24 | — | $-67.0M | ||
| Q1 24 | — | $-243.4M |
| Q4 25 | — | 12.9% | ||
| Q3 25 | — | 6.7% | ||
| Q2 25 | — | -3.1% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | — | -58.1% | ||
| Q2 24 | — | -25.2% | ||
| Q1 24 | — | -119.1% |
| Q4 25 | — | 2.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 0.4% | ||
| Q1 25 | — | 4.6% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | — | 20.1% | ||
| Q2 24 | — | 8.4% | ||
| Q1 24 | — | 12.9% |
| Q4 25 | 3.39× | — | ||
| Q3 25 | 1.91× | — | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SEDG
| Other | $197.7M | 59% |
| Europe Except Netherlands | $99.4M | 30% |
| Others | $38.2M | 11% |
